We are live on ! Find out more
IEIH

iShares Evolved U.S. Innovative Healthcare ETF

Delisted

IEIH was delisted on the 22nd of August, 2022.

9 hedge funds and large institutions have $1.47M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

50% more funds holding

Funds holding: 69 (+3)

6% more capital invested

Capital invested by funds: $1.39M → $1.47M (+$81.5K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

IEIH Hedge Fund Activity: Q2 2020 in Review

9 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q2 2020, worth a combined $1.47M — up 5.9% from $1.39M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IEIH positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $442K. The largest seller was BlackRock, cutting an estimated $1.15M.

  • 9 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q2 2020, up from 6 in Q1 2020.
  • Funds reported $1.47M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q2 2020, up 5.9% quarter-over-quarter.
  • 4 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q2 2020 and 1 closed out, a net change of +3 holders.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q2 2020 was Susquehanna International Group, an estimated $442K added.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q2 2020 was BlackRock, an estimated $1.15M sold.

Based on aggregated 13F filings for Q2 2020.